Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Claudia Praehauser"'
Autor:
Michael Mayr, Klaus Reither, Nikolai Carl Hodel, Ali Hamad, Grace Mwangoka, Irene Kasella, Claudia Praehauser, Salim Abdulla, Christoph F R Hatz
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
Introduction Epidemiological data about diabetes mellitus (DM) for sub-Saharan Africa (SSA) are scarce and the utility of glycated hemoglobin (HbA1c) to diagnose DM is uncertain in African populations with a high proportion of anemia.Research design
Externí odkaz:
https://doaj.org/article/05438adadfb34b699bf5d6c965b12fd5
Autor:
Nikolai C Hodel, Ali Hamad, Claudia Praehauser, Grace Mwangoka, Irene Mndala Kasella, Klaus Reither, Salim Abdulla, Christoph F R Hatz, Michael Mayr
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205326 (2018)
In sub-Saharan Africa (SSA), epidemiological data for chronic kidney disease (CKD) are scarce. We conducted a prospective cross-sectional study including 952 patients in an outpatient clinic in Tanzania to explore CKD prevalence estimates and the ass
Externí odkaz:
https://doaj.org/article/3e3ae3f6a97f427292db814288ae97c8
Autor:
Claudia Praehauser, Patricia Hirt-Minkowski, Kiymet Saydam Bakar, Patrizia Amico, Eliane Vogler, Stefan Schaub, Michael Mayr
Publikováno v:
Swiss Medical Weekly, Vol 143, Iss 4546 (2013)
QUESTIONS UNDER STUDY: The aim of this study was to evaluate risk factors and outcome of expanded-criteria donor (ECD) kidney transplants in patients with low immunological risk. METHODS: We evaluated graft survival and graft function in 265 recipi
Externí odkaz:
https://doaj.org/article/af8142aad14648c9b4e279a9ca476db5
Publikováno v:
Swiss Medical Weekly, Vol 144, Iss 0102 (2012)
BACKGROUND: Few studies have been published on the control of oral anticoagulation treatment in end stage renal disease (ESRD). METHODS: To analyse the quality of oral anticoagulation treatment control in ESRD patients treated with phenprocoumon we
Externí odkaz:
https://doaj.org/article/6b1e98ee5c414b589bc70a5c734c3d00
Autor:
Claudia Praehauser, Nikolai C. Hodel, Christoph Hatz, Ali Hamad, Grace Mwangoka, Salim Abdulla, Klaus Reither, Michael Mayr, Irene Mndala Kasella
Publikováno v:
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
IntroductionEpidemiological data about diabetes mellitus (DM) for sub-Saharan Africa (SSA) are scarce and the utility of glycated hemoglobin (HbA1c) to diagnose DM is uncertain in African populations with a high proportion of anemia.Research design a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6382acb8628bc7aaedd98fee8f19d2f8
Autor:
Claudia Praehauser, Nikolai C. Hodel, Christoph Hatz, Irene Mndala Kasella, Ali Hamad, Grace Mwangoka, Klaus Reither, Michael Mayr, Salim Abdulla
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 10, p e0205326 (2018)
PLoS ONE, Vol 13, Iss 10, p e0205326 (2018)
In sub-Saharan Africa (SSA), epidemiological data for chronic kidney disease (CKD) are scarce. We conducted a prospective cross-sectional study including 952 patients in an outpatient clinic in Tanzania to explore CKD prevalence estimates and the ass
Autor:
Patrizia Amico, Lorenz Gürke, Michael T. Koller, Michael Mayr, Gideon Hönger, Claudia Praehauser, Jürg Steiger, Patricia Hirt-Minkowski, Stefan Schaub
Publikováno v:
Clinical Transplantation. 26:E624-E633
Delayed graft function (DGF) is considered as a risk factor for renal allograft rejection, but this association might be confounded by diagnostic biases (e.g., higher biopsy frequency in patients with DGF, inclusion of clinically diagnosed rejection
Autor:
Michael Dickenmann, Thomas Eugster, Michael Mayr, Claudia Praehauser, Cora Nina Moser-Bucher, Katrin Baechler, Thomas Wolff, Tobias Breidthardt, Lorenz Gürke
Publikováno v:
Clinical Kidney Journal
Background The American Fistula First Breakthrough Initiative currently aims for a 66% arterio-venous fistula (AVF) rate, while in the UK, best practice tariffs target AVF and arterio-venous graft (AVG) rates of 85%. The present study aims to assess
Autor:
Kiymet Saydam Bakar, Patrizia Amico, Stefan Schaub, Eliane Vogler, Claudia Praehauser, Patricia Hirt-Minkowski, Michael Mayr
Publikováno v:
Swiss Medical Weekly.
Summary QUESTIONS UNDER STUDY: The aim of this study was to evaluate risk factors and outcome of expanded-criteria donor (ECD) kidney transplants in patients with low immunological risk. METHODS: We evaluated graft survival and graft function in 265
Publikováno v:
Swiss Medical Weekly.
Few studies have been published on the control of oral anticoagulation treatment in end stage renal disease (ESRD).To analyse the quality of oral anticoagulation treatment control in ESRD patients treated with phenprocoumon we conducted a cohort stud